Trial Profile
An 8-Week, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of Gemcabene Administered as Monotherapy or in Combination With Atorvastatin in the Treatment of Hypercholesterolemic Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Gemcabene (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Gemphire Therapeutics; NeuroBo Pharmaceuticals
- 10 Feb 2016 New trial record